These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31967117)

  • 21. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
    Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
    J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
    Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
    Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
    [No Abstract]   [Full Text] [Related]  

  • 23. CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens.
    Abdul Momin MHF; Bean DC; Hendriksen RS; Haenni M; Phee LM; Wareham DW
    J Med Microbiol; 2017 Nov; 66(11):1554-1561. PubMed ID: 28984232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
    Ruzaimi MY; Shahril Y; Masbah O; Salasawati H
    Med J Malaysia; 2006 Feb; 61 Suppl A():21-6. PubMed ID: 17042224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Olaitan AO; Morand S; Rolain JM
    Int J Antimicrob Agents; 2016 Jan; 47(1):1-3. PubMed ID: 26712133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods.
    Osei Sekyere J; Govinden U; Bester LA; Essack SY
    J Appl Microbiol; 2016 Sep; 121(3):601-17. PubMed ID: 27153928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
    Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
    Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program.
    Al Rahmany D; Albeloushi A; Alreesi I; Alzaabi A; Alreesi M; Pontiggia L; Ghazi IM
    Int J Infect Dis; 2019 Jun; 83():77-82. PubMed ID: 30959249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance cultures for detection of rectal and lower respiratory tract carriage of colistin-resistant Gram-negative bacilli in intensive care unit patients: comparison of direct plating and pre-enrichment step.
    Germ J; Cerar Kišek T; Kokošar Ulčar B; Lejko Zupanc T; Mrvič T; Kerin Povšič M; Seme K; Pirs M
    J Med Microbiol; 2019 Sep; 68(9):1269-1278. PubMed ID: 31237536
    [No Abstract]   [Full Text] [Related]  

  • 34. Colistin: Revival of an Old Polymyxin Antibiotic.
    Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; Ortiz-Zacarías NV; van Nieuwkoop C; Verbrugh HA; Touw DJ
    Ther Drug Monit; 2015 Aug; 37(4):419-27. PubMed ID: 25549206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin resistance in non-fermenting Gram-negative bacilli in a university hospital.
    Santos SO; Rocca SM; Hörner R
    Braz J Infect Dis; 2016; 20(6):649-650. PubMed ID: 27755978
    [No Abstract]   [Full Text] [Related]  

  • 37. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?
    Al-Tawfiq JA; Laxminarayan R; Mendelson M
    Int J Infect Dis; 2017 Jan; 54():77-84. PubMed ID: 27915108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrothermal derived protoporphyrin IX nanoparticles for inactivation and imaging of bacteria strains.
    Ning LG; Liu P; Wang B; Li CM; Kang ET; Lu ZS; Hu XF; Xu LQ
    J Colloid Interface Sci; 2019 Aug; 549():72-79. PubMed ID: 31022525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
    Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y
    Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.